机构：[1]Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China四川省人民医院[2]State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China四川大学华西医院[3]School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0250, USA
第一作者机构：[1]Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China[3]School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0250, USA
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Yang Zhenyu,Zhou Yangli,Zhong Lei.Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation.[J].BIOORGANIC & MEDICINAL CHEMISTRY LETTERS.2021,33:doi:10.1016/j.bmcl.2020.127745.
APA：
Yang Zhenyu,Zhou Yangli&Zhong Lei.(2021).Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation..BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,33,
MLA：
Yang Zhenyu,et al."Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation.".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 33.(2021)
